Femtosecond laser-assisted cataract surgery: One physician’s story
Ophthalmologist outlines his journey with the procedure as a late adopter.
Ophthalmologist outlines his journey with the procedure as a late adopter.
Priorities can ensure optimal outcomes for patients diagnosed with diseases.
The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of…
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference.
The A-IOL aims to correct both near and distance eyesight, reduce reliance on glasses or contact lenses, have no glare or halos, and restore the…
The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of…
The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, Maryland.
David Hutton, Managing Editor of Ophthalmology Times sat down with Claris Bio CEO, Clarke Atwell, to discuss the company’s path toward developing treatment for neurotrophic…
Kamuvudine-8, also known as K8, is administered to the back of the eye via a sustained released intravitreal implant.
The A-IOL aims to correct both near and distance eyesight, reduce reliance on glasses or contact lenses, have no glare or halos, and restore the…